Title : Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab.

Pub. Date : 2009 Feb

PMID : 18682948






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The humanized, anti-CD52 monoclonal antibody alemtuzumab (Campath or Campath-1H) has shown notable activity for both untreated and fludarabine-refractory CLL. fludarabine CD52 molecule Homo sapiens